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Abstract .  Photodynamic therapy (PDT) is a treatment modality with potential application for 
premalignant lesions and squamous cell carcinoma of the oral mucosa. PDT in principle has dual 
selectivity. This may result from a 'preferential' retention of the photosensitizer in target tissue. 
In addition, the photodynamic activity will be limited to the irradiated area because PDT will 
not affect tissues in the absence of excitation light. The specificity of PDT is limited by the fact 
that normal tissues also retain the photosensitizer to some degree, which makes these tissues 
susceptible to PDT damage. To optimize PDT for oral malignancies, a study was undertaken on 
normal tissue to investigate the responses in rat palatal mucosa and surrounding anatomical 
structures. Eighty male Wistar rats were used in the study. Photofrin was administered i.v. at four 
doses (0, 2.5, 5 or 10 mg kg - 1 body weight). Irradiation for PDT was performed 24 h later. An argon 
pumped dye laser system was used to produce light of two different reatment wavelengths (514.5 
and 625 nm), and various energy density levels (0, 25, 50, 100 or 200 J cm-  2). Early effects of PDT 
were studied at 2 days and late effects at 2 months after treatment. Twenty-four hours after i.v. 
administration of Photofrin, it was found that PDT affects normal tissues of the oral cavity both 
macroscopically and microscopically. Combinations of photosensitizer doses _> 5 mg kg - 1 and light 
doses _>100J cm -2 caused severe and permanent damage to the palatal mucosa and adjacent 
normal structures uch as palatal bone and dentition. 
Light scattering and internal reflection usually raise the fluence rate in tissue above the 
irradiance of the incident beam. In an additional study using six male Wistar rats, the energy 
fluence rate at two treatment wavelengths (514.5 and 625 nm) was measured ex vivo in the palatal 
mucosa and adjacent anatomical structures. As expected, the energy fluence rates were wave- 
length, tissue and depth dependent. At the air-mucosa boundary, light of 625 nm was found to have 
a three-times higher fluence rate than the primary incident beam. Under similar conditions, the 
fluence rate of 514.5 nm was found to be less, but still twice as high as the primary incident beam. 
At deeper levels of the rat maxilla, fluence rates were still elevated compared with the incident 
beam. For 625 nm light, this phenomenon was observed up to the level of the nasal cavity. These 
increased fluence rates could largely explain the pattern of damage to normal mucosa and 
surrounding anatomical structures. 
INTRODUCTION 
Photodynamic therapy (PDT) is a treatment 
modality with potential application for prema- 
lignant lesions and squamous cell carcinoma 
of the oral mucosa. PDT is based on the dye- 
sensitized photo-oxidation f biological matter 
in the target tissue (1). The photosensitizers 
Haematoporphyrin derivative (HpD), or more 
commonly Photofrin (the semi-purified version 
0268-8921/96/030163+12 $12.00/0 9 1996 W.B. Saunders Company Ltd 
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of HpD, enriched in the 'active fraction'), are 
frequently used for PDT. Currently, a number 
of photosensitizers are being clinically tested, 
but to date Photofrin is the only photosensi- 
tizer that has been approved for a limited 
number of indications in the USA, Canada, 
Japan and the Netherlands. The advantage of 
PDT over conventional surgical or radiothera- 
peutic treatment may be its potential dual 
selectivity. Selectivity may be obtained by a 
'preferential' retention of the photosensitizer 
in target issue. In addition, the photodynamic 
activity will be limited to the irradiated area 
because PDT will not affect tissues in the 
absence of excitation light. However, the 
selectivity of Photofrin is far from ideal 
because normal tissue also retains the photo- 
sensitizer to some extent, and is, therefore, 
susceptible to PDT damage (2-6). Knowledge 
of the morphological alterations induced by 
PDT in the area of the tumour and in the 
region of the adjacent normal tissues is there- 
fore important with respect o the early and 
late complications of PDT (7). Furthermore, it 
is important o determine the optimal combi- 
nation of photosensitizer and light dose that 
will result in minimal or at least reversible 
damage to the surrounding normal tissues. 
Proper knowledge of light dosimetry is, there- 
fore, needed in order to compare, reproduce 
and predict he effects of PDT, and to establish 
the factors that determine success or failure. 
However, so far little attention has been paid 
to light dosimetry in clinical PDT (8-11). Fre- 
quently, the distribution of the photosensitizer 
in tissue remains unknown, and consequently, 
the actual ight dose absorbed by the photosen- 
sitizer is unknown. In PDT of superficial 
tumours, the incident power per unit area (W 
m-2) multiplied by the irradition time is used 
to describe the light dose. In tissue, the energy 
fluence rate can vary, however, due to the 
phenomena of light scattering and internal 
reflection at tissue boundaries. In oral tissue 
there are potentially many boundaries which 
could influence the homogenous distribution 
of light, eg the air mucosa and mucosa bone 
boundaries. Better knowledge of the distribu- 
9 tion of light in the treated tissues can be 
obtained by calculations using a mathematical 
description of light propagation in tissue, 
using estimates of the scattering properties 
and optical absorption of the treated tissue, 
and by in vivo measurement of the fluence rate 
of light (1~15). This may help to understand 
the treatment results. 
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Red light in the range of 625-630nm is 
most commonly used in clinical PDT with 
porphyrin-based photosensitizers uch as 
Photofrin. Although porphyrins have a low 
absorption at these wavelengths, this excita- 
tion wavelength is often chosen because of its 
increased optical penetration compared with 
light of shorter wavelengths. For PDT of small, 
superficially growing tumours, the use of 
514.5 nm green light might be preferred. The 
porphyrin molecule can be excited at a wave- 
length where it has a higher absorption, and 
damage to anatomical structures beyond the 
target volume can be minimized (16-18). 
The aim of this study was two-fold. First, to 
describe the effect of PDT on normal rat pala- 
tal mucosa and surrounding normal tissues; 
various combinations of photosensitizer and 
light doses at two different reatment wave- 
lengths were compared. Second, to describe 
light fluence as a function of wavelength and 
site in the normal rat palate and adjacent 
anatomical structures using the two most 
common excitation wavelengths for Photofrin 
excitation, and to compare this with the 
treatment results. 
MATERIALS  AND METHODS 
An imals  
Eighty healthy, 6-8-week-old male Wistar rats 
(CDL-Groningen, The Netherlands) were used 
in this study. The rats were randomly divided 
into two groups of 40 rats. One group was 
treated with light of 625 nm, based on the study 
of Star et al (12), and the other group was 
treated with light of 514.5 nm. Each group of 
40 rats was again randomly divided into 10 
groups of four rats. Each group of four rats 
was treated with a different combination of 
photosensitizer dose and light dose (Table 1). 
During administration of the photosensitizer 
and during photodynamic therapy, the animals 
were anaesthetized with a combination of 
NsO/O2/Halothane. Approval for this study 
was obtained from the University Animal 
Experiments Committee (FCC-0472). 
Excitat ion l ight 
A tuneable argon pumped dye laser system 
(Spectra-Physics, 171 and 375B) was used to 
produce 514.5 nm (green) light or 625 nm (red) 
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Table 1. Summary of the treatment plan of the 
effect of PDT on normal rat palatal mucosa and 
surrounding anatomical structures 
Incident 
Protocol Number Photofrin dose 
number of rats (mg kg-1  bw) light dose 
(J cm - 2) 
I 8 0 200 
II 8 2.5 200 
III 8 2.5 100 
IV 8 5 100 
V 8 2.5 50 
VI 8 5 50 
VII 8 10 50 
VIII 8 5 25 
IX 8 10 25 
X 8 10 0 
The irradiance of both treatment wavelengths (514.5 and 
625 nm) was 60 mW cm -2 and the photosensitizer-light 
interval was 24 h. Half of the animals of each treatment 
protocol were killed after 2 days to examine the 
short-term effects. The remaining rats were kept alive up 
to 2 months after treatment to examine the long-term 
effects. 
light. The fluence rate  of the incident beam for 
both wavelengths was 60 mW cm-2 ,  and the 
l ight dose was 0-200 J cm-2  (Table 1). A l ight 
del ivery system was developed which enabled 
the del ivery of l ight to an area of about  
10 mm in diameter, corresponding with the 
intermolar  area of the rat  palate (19). 
Photodynamic therapy 
Each rat  was photosensit ized with either 0, 2.5, 
5 or 10 mg kg 1 bw Photofr in  (Quadra Logic 
Technologies,  Vancouver,  BC, Canada), by 
int ravenous inject ion in the tail vein. The 
animals were housed under  reduced l ight con- 
dit ions to avoid unwanted  photodynamic  
action. Twenty-four hours after administ rat ion 
of the photosensit izer,  the palates were irradi- 
ated. From every t reatment  group, two rats 
were ki l led 48 h after PDT and two after 2 
months,  to examine both short- and long- 
term effects. The rats  were ki l led by an intra- 
cardial  in ject ion of sodium pentobarb i ta l  
(Euthesate). 
Histological preparation 
The palate,  including the surrounding hard 
and soft tissues, was removed in one piece and 
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photographed.  The specimens were fixed in 
4% formalin, and subsequent ly decalcif ied 
for approx imate ly  4 weeks in 25% formic acid 
with 0.34M tr isodium citrate dihydrate. The 
degree of decalcif ication was checked by X-ray 
analysis. The palates were dehydrated and 
embedded in paraffin. Histology slides of 7/ lm 
were cut t ransverse ly  through the region of 
the second molar.  The slides were stained with 
Haematoxy l in  and Eosin (HE) for examinat ion 
by l ight microscopy.  
Macroscopic scoring system 
Changes in the macroscopic  appearance of 
the dissected palates 2 days after PDT treat- 
ment  were given a numer ica l  score: 0=no 
cl inical effect, 1=sl ight  erythema, 2=marked  
erythema, 3=ulcerat ion  or necrosis of the epi- 
thel ium (focal), 4 = u lcerat ion or necrosis of the 
epithel ium (entire area), 5 = denuded bone. 
Subsequently,  the macroscopic  appearance 
of the palate 2 months after PDT was given 
a score: 0=no cl inical effect, 1=epi the l ium 
intact, scar t issue (locally), 2=epi the l ium 
intact, scar t issue (entire area), 3=ulcerat ion  
or necrosis of the epithel ium, 4= denuded bone 
(locally), 5= denuded bone (entire area). 
Microscopic scoring system 
The histological  changes were described using 
two grading systems. One described the short- 
term histological  effects (2 days after PDT), the 
other the long-term histological  effects (2 
months after PDT). In both grading systems, 
effects seen in the mucosa, the pa lata l  bone 
and in st ructures beyond the palata l  bone were 
evaluated separately.  Each item of both 
systems was given a numer ica l  score which 
var ied from 0 to 2 (0=no effect, 1=sl ight  effect, 
2=marked  effect). The overal l  PDT- induced 
damage score is summarized by adding up 
these individual scores. For the short-term 
effects (2 days after PDT), the max imum poss- 
ible score of this grading system was 54; for the 
long-term effects (2 months after PDT), this 
was 40. 
Microscopic changes 2 days after PDT were 
examined for the fol lowing items: 
Mucosa:  oedema, haemorrhage,  parakeratos is ,  
part ia l  or total  necrosis of the epithel ial  
layer, vascular  oedema, congest ion or haemos- 
tasis of vessels, vascu lar  thrombosis,  vascu lar  
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necrosis, disruption of lamina elastica interna 
of arteries. 
Bone: intra-suture tissue haemorrhage, intra- 
suture tissue necrosis, osteocyte necrosis, bone 
marrow haemorrhage, haematopoietic cell loss 
of bone marrow. 
Beyond mucosa: oedema, haemorrhage, vascu- 
lar oedema, congestion or haemostasis of 
vessels, vascular thrombosis, vascular necro- 
sis, disruption of lamina elastica interna of 
arteries, dental pulpa necrosis, increased 
degranulation of Goblet cells, cell necrosis of 
sinal epithelium, necrosis of the lacrimal 
gland. 
Microscopic changes 2 months after PDT 
were examined for the following items: 
Mucosa: irregular distribution of rete ridges, 
epithelial isles or cysts, scar tissue, foreign 
body reaction in mucosa, hypertrophy of 
vessel wall, vascular ecanalization, vascular 
proliferation, neuronal proliferation, loss of 
palatal artery and vein, loss of palatal nerve. 
Bone: palatal bone remodelling, loss of palatal 
bone. 
Beyond mucosa: scar tissue, hypertrophy of 
vessel wall, vascular ecanalization, vascular 
proliferation, neuronal proliferation, dental 
hard tissue resorption, ankylosis of root, 
irregular dentin formation, hyperplasia of 
sinus epithelium. 
Dos imetry  exper iment  
Due to the small dimensions of the rat 
oral cavity, it was impossible to perform do- 
simetry measurements in vivo. Therefore, 
these measurements were performed ex vivo 
(ie immediately after dissection of the palate 
and surrounding structures). Six male Wistar 
rats were used in this dosimetry experiment. 
An isotropic probe (ie a fibre-optic light detec- 
tor with omnidirectional uniform response) of 
0.8 mm diameter was calibrated in a parallel 
beam of light (514.5 and 625 nm wavelength) 
with an irradiance of 100 mW cm - 2. This beam 
of 10ram diameter was then directed to the 
palate simulating the light beam of the light 
delivery system, as used in the PDT exper- 
iments. Due to differences in isotropic probe 
response in tissue after calibration in air due 
to differences in refractive index, the readings 
of the probe were corrected by a factor of 1.65 
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Fig. 1. Schematic drawing of the mucosa, hard palate and 
surrounding structures of the rat maxilla at the level of the 
second molar in a sagittal plane. The sites where the 
fluence measurements were taken are indicated. These 
include: (A) on the air-mucosa boundary, (B) at the 
mucosa-bone boundary, (C) in the nasal cavity, (D) in the 
lacrimal gland in close proximity to the molar teeth, (E) in 
the lacrimal gland, close to the brain. 
when the probe was completely surrounded by 
tissue, and by a factor of 1.15 when partly 
surrounded by tissue and partly by air (20, 21). 
Figure 1 shows a schematic drawing in a 
sagittal plane through mucosa, hard palate 
and surrounding structures of the rat maxilla 
at the level of the second molar. The various 
sites of the palatal mucosa and surrounding 
structures where the light fluence measure- 
ments were taken are indicated. These include: 
(A) the air-mucosa boundary, (B) the mucos~ 
bone boundary, (C) the nasal cavity, (D) the 
lacrimal gland in close proximity to the molar 
teeth, and (E) the lacrimal gland close to the 
brain. 
In order to estimate the influence of internal 
reflection by bone, and to simulate the clinical 
situation when palate is lost due to tumour 
invasion, the epithelium of the intermolar area 
was dissected. Measurements were taken on 
top of and underneath this dissected mucosa 
specimen (on a black non-scattering back- 
ground), directly on the denuded palatal bone, 
and in the nasal cavity. Comparing the results 
of the measurements in which the mucosa 
was still attached to the palatal bone, with 
those where the palatal mucosa was dissected 
and placed on a black background, yields an 
estimate of the portion of the light that is 
reflected by the palatal bone back into the 
PDT of Rat Palatal Mucosa 
300 ~ .~ 
280 ~--~.T 
~o ~- ~ ~ ~25 ~m 
! 22~ -~ --~514.5 
200~ ~ -- 100mWcm -2 
180 P- ~ \ 
140 ~- ~ \ 
12o b \ x_ 1oo  . . . .  . . . . . . . . . . . . . . . . .  
z ~ z 
Fig. 2. Diagram showing the results of the isotropic probe 
measurements of the energy fluence rates of 514.5 and 
625 nm excitation light at various sites of the oral cavity and 
surrounding structures, with the palatal rnucosa in situ. The 
fluence rate of the primary incident beam (calibrated in air) 
was 100 mW cm -2. The beam diameter was 10 mm. 
mucosa and the l ight that  is scattered by the 
mucosa only. 
RESULTS 
During follow-up, the rats  were weighed twice 
a week. After an init ial  sl ight loss of weight 
during the first week after t reatment,  all rats  
showed an increase in weight, but no cor- 
re lat ion was found between weight and 
t reatment  parameters .  
Dosimetry 
Figure 2 shows a line d iagram of the fluence 
rates of the rat  pa lata l  mucosa and surround- 
ing structures for both excitat ion wave- 
lengths. The measurements  plotted in this 
graph were taken  with the mucosal  layer in 
situ. The fluence rates at 625 nm were always 
higher than  those of 514.5 nm, and found to 
be signif icantly different in a paired Student 's  
t-test (p<0.05). At the surface of the mucosa, 
the fluence rate at 625 nm was almost three 
t imes higher than  that  of the pr imary  
incident l ight beam. At the mucosa-bone  
boundary,  the fluence rate was more than  2.5 
times higher. The fluence rate of l ight at 
514.5 nm was two t imes higher at the surface 
of the mucosa, and at the mucosa-bone  
boundary  exceeded the i r radiance of the 
incident beam. 
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In Table 2, the actual  f luence rates and 
addit ional  measurements  taken  after dissec- 
t ion of the pa lata l  mucosa are listed. Overal l  
results indicate that  both mucosa and palata l  
bone contr ibuted considerably to l ight scatter- 
ing and internal  reflection. The measurements  
taken after dissection of the pa lata l  mucosa 
showed that  the average fluence rate of 
514.5 nm l ight at the mucosa-a i r  boundary  
was about  0.8 t imes the value measured while 
the palata l  mucosa was still a t tached to the 
palhtal  bone. Under  s imilar condit ions, the 
average fluence rate  of 625 nm l ight was about  
0.7 times the value measured while the pa lata l  
mucosa was stil l a t tached to the pa lata l  
bone. Measurements  underneath  the dissected 
palata l  mucosa also revealed a decrease of 
the actual  f luence rate  of 0.8 and 0.7 t imes for 
514.5 nm and 625 nm, respectively. 
Macroscopic changes 
Figure 3(a,b) depicts the mean overal l  macro- 
scopic damage score 2 days after t reatment  of 
the normal  palate with var ious combinat ions 
of photosensit izer  and l ight doses for both 
t reatment  wavelengths.  As expected, the effect 
on the normal  palate and surrounding struc- 
tures of the oral cavity was found to be~hoth 
sensitizer- and l ight-dose dependent.  H igher  
sensit izer doses and h igher  l ight doses resulted 
in more damage than  combinat ions in which 
lower drug, or lower l ight doses, were used. 
Except for one rat  in which local ly denuded 
bone was evident, the most severe damage of 
the mucosa presented as u lcerat ion or necrosis 
with haemorrhage  and oedema of the entire 
t reated area. When no sensit izer or no l ight 
was applied, no cl inical damage of the mucosa 
of the intermolar  area was observed. Two days 
after PDT, no real  difference was observed in 
the amount  of macroscopic  damage between 
the two t reatment  wavelengths.  
In Fig. 3(c,d) the mean overal l  macroscopic  
damage score at 2 months after t reatment  
is shown. For  most  of the combinat ions of 
sensit izer- l ight doses, the epithel ium of the 
intermolar  area had macroscopical ly  regener- 
ated to an intact  epithel ial  ayer. In the major- 
ity of cases, however,  scar t issue was evident. 
In these cases, the appearance of the normal  
anatomy of the intermolar  area was disturbed. 
The rugal  pat tern  had disappeared and the 
palata l  mucosa gave a more whit ish dense 
impression in which the under ly ing pa lata l  
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Table 2. Isotropic probe measurements of the fluence rates of light of 514.5 and 
625 nm at various sites of the rat oral cavity and surrounding structures 
514.5 nm wavelength 625 nm wavelength 
Mean s.e.m. (%) Mean s.e.m. (%) 
Before dissection of the palatal mucosa 
Air-mucosa boundary (A*) 207 6 291 3 
Mucosa-bone boundary (B*) 153 13 265 8 
Nasal cavity (C*) 25 9 106 9 
Lacrimal gland-near molars (D*) 17 24 48 14 
Lacrimal gland-near brain (E*) 1 14 6 15 
After dissection of the palatal mucosa 
At the mucosa (black background) 166 7 207 3 
Under the mucosa (black background) 129 6 189 6 
On denuded palatal bone 194 6 287 4 
Nasal cavity 55 14 158 7 
The fluence rate of the primary beam (calibrated in air) was 100 mW cm- 2. Measurements were 
taken both before and after dissection of the palatal mucosa to examine the specific influence of 
mucosa nd bone on the fluence rates. A*-E* corresponds with the sites as depicted in Fig. 1. 
514.5 nm I (a )  
2 days 
100 
Light dose 
(J cm -2) 
625 nm 2~ 2 days
100 
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Fig. 3. The overall macroscopic damage scores 2 days and 2 months after PDT. (a) Two days after PDT, at 514.5 nm. 
(b) Two days after PDT, at 625 nm. (c) Two months after PDT, at 514.5 nm. (d) 2 months after PDT, at 625 nm. The x-axis 
represents the light dose in Jcm -2, the y-axis the damage score, and the z-axis the Photofrin dose in mg kg -1 bw. 
blood vessels were no longer visible. In three 
rats, the epithel ia l  integrity was disturbed 
with the denuded palatal bone clearly visible. 
Two of these rats were treated with 625 nm, 
the other with the 514.5 nm, all in Protocol  IV. 
The absence of photosensit izer o light in the 
initial t reatment caused no observable dam- 
age, result ing in normal macroscopic appear- 
ance of the palatal mucosa. Overall, no 
apparent differences were found between the 
two treatment wavelengths in the amount of 
macroscopic damage at 2 months. 
Microscop ic  changes  
Figure 4(a,b) shows the mean overall micro- 
scopic damage score of the effect of PDT on the 
normal palate and surrounding structures of 
the rat oral cavity, 2 days after treatment. The 
overall damage effect of light of 625nm 
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Fig. 4. The overall microscopic damage scores 2 days and 2 months after PDT. (a) Two days after PDT, at 514.5 nm. 
(b) Two days after PDT, at 625 nm. (c) Two months after PDT, at 514.5 nm. (d) Two months after PDT, at 625 nm. The x-axis 
represents the light dose in Jcm -2, the y-axis the dama.ge score, and the z-axis the Photofrin dose in mg kg -1 bw. 
exceeded that of light of 514.5 nm. For both 
excitation wavelengths, this overall effect 
increases with increasing Photofrin dose, as 
well as with increasing light dose. The damage 
score of light at 625 nm mainly exceeded 
that at 514.5 nm because of effects on struc- 
tures beyond the palatal bone. As expected, the 
highest Photofrin dose (10 mg kg-1) used in 
this study caused no measurable effect in the 
absence of light (Protocol X). On the other 
hand, a high dose of light (200 J cm- 2) in the 
absence of the photosensitizer (Protocol I), 
resulted in a small but distinctive amount of 
damage. This effect was present for both wave- 
lengths, and was noticed only in structures 
beyond the palatal bone (ie epithelium of the 
nasal sinus and lacrimal gland). 
Figure 4(c, d) shows the mean overall micro- 
scopic damage score 2 months after PDT. At 
this time, in contrast o the effects seen at 2 
days after PDT, the tissue damage of light of 
514.5 nm exceeded that of 625 nm. When dam- 
age to mucosa, palatal bone and structures 
beyond the palatal bone were judged separ- 
ately, the long-term damage to the mucosa was 
found to contribute most to the overall conclu- 
sion that light at 514.5 nm was more damaging 
than that at 625 nm. Most striking differences 
between the mucosa scores of both wave- 
lengths were found in Protocols II and III. The 
minor damage caused by light alone, as 
observed at 2 days, was not present at 2 
months. Increasing the drug dose or the light 
dose resulted in more permanent damage at 
2 months. 
One of the presumptions of PDT is that 
damage to normal tissues should be at least 
reversible. However, it was found that several 
combinations of photosensitizer and light 
doses resulted in permanent tissue damage 
(Fig. 5). This permanent damage was found 
to be sensitizer, light-dose and wavelength 
dependent. For both wavelengths, a marked 
loss of the palatal bone was found in Proto- 
cols IV and VI. In other combinations of 
sensitizer and light doses (except Protocols I
and X), bone remodelling or partial loss of 
the palatal bone was apparent. At 2 months, 
the effect of light of 514.5 nm on bone slightly 
exceeded that of 625 nm. Damage to molar 
teeth was found for both wavelengths. Dam- 
age was composed of resorption of dental 
hard tissues, ankylosis of the root (ie a bony 
attachment of the root with the surrounding 
alveolar bone, indicating regeneration after 
previous damage to the periodontal iga- 
ment), and the formation of irregular dentin, 
For both wavelengths (except in Protocols I, 
V and X), damage to the dental hard tissue 
was evident. No apparent differences existed 
in the degree of damage to the dental hard 
tissue induced by either wavelength. Further- 
more, it was found that in all cases (except in 
Protocols I, V and X), epithelial inclusion 
cysts were found within the regenerated 
epithelium (Fig. 6). 
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Fig. 5. Some typical examples of the histological appearance of the rat palatal mucosa after PDT. (a) Normal, untreated 
palatal mucosa. E=epithelial layer of the palatal mucosa, S=submucosa, P=palatal bone, M=molar (HE, x40). (b) Two days 
after PDT. Treatment parameters: 625 nm, 5 mg kg -1, 100 J cm -2. Complete loss of epithelium, bacterial overgrowth in 
submucosal tissue and around vessels. Severe periosteal oedema. N=necrotic epithelial ayer (HE, x40). (c) Two months after 
PDT with more or less reversible damage. Treatment parameters: 514.5 rim, 5 mg kg -1, 50 J cm -2. The palate shows a 
normal intact epithelium with normal hyperkeratosis. The submucosa consists of a dense collagen-rich tissue (scar tissue) with 
epithelial islands within the submucosa. ST=scar tissue in the submucosa, X=epithelial islands and epithelial cyst in the 
submucosa (HE, x40). (d) Two months after PDT with irreversible damage. Treatment parameters: 625 nm, 5 mg kg -1, 
100 J cm -2. Note the marked loss (BL) of palatal bone (HE, x40). 
DISCUSSION 
In order to treat premalignant epithelial 
lesions and squamous cell carcinoma of the 
oral mucosa with PDT, it is important to 
understand the effects on normal tissues. 
Sparing, or at least regeneration, of normal 
tissue is necessary in order to preserve func- 
tion. Not only is it important o assess the 
'treatment window' (the range of optimal com- 
binations of sensitizer and light doses), but 
also to understand the light distribution in 
tissues to gain more knowledge of factors that 
lead to tissue effects. Among the large nmnber 
of PDT studies, the effect of normal tissue and 
light distribution has received relatively little 
attention (12, 22-26). 
Light dos imetry  
Light scattering and internal reflection 
strongly influence the energy fluence rates in 
different tissues. The results of the present 
experimental study on the fluence rates in 
normal rat palates show that the distribution 
of light in oral tissue is far from homogenous. 
Palatal mucosa nd palatal bone influence the 
fluence of 514.5 and 625 nm light. Energy flu- 
ence rates at the air mucosa boundary were 
found to be twice as high for 514.5 nm light and 
three times as high for 625 nm light, relative to 
the primary incident beam with an irradiance 
of 100 mW cm-~. The fluence rates of 625 nm 
light were always higher than those of the 
514.5nm. This was expected because the 
absorption and scattering properties of tissue 
for green light is different from those of red 
light, and longer wavelengths can penetrate 
deeper in tissues. 
The conclusions of the present study are in 
accordance with those of Star and Marijnissen 
et al (8, 13, 27, 28). At several tissue surfaces 
(chicken muscle, rhabdomyosarcoma, dog 
bladder), they found actual fluence rates that 
were two to six times higher than the primary 
incident beam. Light of 630nm gave higher 
actual fluence rates than 514.5 nm light. In 
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Fig. 6. Histological appearance of the long-term (2 months after treatment) specific damage of the rat palatal mucosa and 
surrounding tissues. (a) Under a normal intact epithelium wi~h normal hyperkera!os S epithe!ia! islands (inclusion cysts)with 
Sebaceous differentiation, complete loss Of the palatal vessel and nerve bundle can Be seen. x=inClusion cyst, BL=palatal 
6one loss. Treatment p~rameters: 514.5 nml 5 mg kg -~, i00 J cm -2 (HEI x64). (6} Marked loss of paiatal bone. BL=palatal 
b65e loss. Treatment parameters: 625 nml 10mg kg -~, 50 3 cm -2 (HE; x64). (e) Damage to dental hard tissue and dental 
pulp. Root resportion (R) and formation of irregular dentin (I) can be seen. Treatment parameters: 625 rim, 5 mg kg -~, 
50 J cm -2 (HE, x64). (d) Revascularization of the palatal artery (R) and proliferation of the palatal nerve (N) due to previous 
damaqe. Treatment parameters: 514.5 nm, 10 mg kg -~, 25 J cm -a (HE, x160). 
human whole bladder wall~ PDT (630nm) 
revealed a true light fluence (ie non-scattering 
incident light plus scattered light) almost five 
times larger than the non-scattered incident 
light fluenee. In rat ears, Star et al (12) found 
the actual Iight fluence to be ~ig~er than the 
incident fluence. These actual fluence rates 
correlated with the relative biological effect, 
rather than with the incident fluence. 
The results of the present dosimetry study 
clearly indicate that  an incident tight beam 
wigh an energy fluenee of 100 mW cm- 2 at the 
mueosa results in a true ener~ fluence rate 
which is twice as high for light of 514.5 nm and 
three times as high for light of 625 nm. Other 
structures in close proximity to the palatal 
mucosa, eg dentition, nasal  cavity and lac- 
rimal gland, therefore received ~igher doses of 
t ight: In this study, these increased fluenee 
rates contribute considerably to PDT-induced 
damage of normal anatomical structures, The 
fluenee-rate data largely explain the damage 
pattern seen in this study. 
Normal  t i ssue  ef fects  
Knowledge of the morphological  alterations 
induced by PDT,  not only in the area of the 
tumour  but also in the region of the adjacent 
normal  tissue, is important wi th  respect to the  
early and  late compl icat ions of PDT (7). The  
mechan ism of accumulat ion of photosensi- 
tizers in tumour  tissue is still largely un- 
known.  Autoradiographic  studies using [~4C]- 
and [3H]-labelled porphyrins have demon-  
strated photosensitizer uptake in  normal  
tissue (2-4, 29). As  normal  tissue also retains 
the pho~osensitizer to some extent, it ~s a~so 
susceptible to PDT.  The  feasibility of clinical 
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PDT is determined, in part, by the response of 
normal tissue adjacent o tumour tissue. The 
ideal is to find an optimal therapeutic window, 
combining photosensitizer dose and light dose. 
Treatment under these parameters should lead 
to tumour destruction with only limited or at 
least reversible damage to the surrounding 
tissues. As seen in the present study, 2 days 
after PDT, the effect of 625 nm light exceeded 
that of 514.5 nm, due to damage of structures 
beyond the mucosa. At 2 months, these effects 
were reversed, caused by permanent damage of 
the mucosal ayer. Dosimetry experiments in 
mucosa and structures beyond the mucosa 
revealed that actual fluence rates of 625 nm 
light were higher than those of 514.5 nm. 
Although light of 625 nm penetrates deeper 
into tissue, the increased absorption of 
514.5 nm apparently results in more permanent 
damage (at a smaller tissue volume). The 
observation that light alone resulted in dis- 
tinctive damage 2 days after PDT can be 
explained by the presence of endogenous 
porphyrins. For example, the Harderian gland, 
a lipid-secreting gland in the orbit in rodents, 
contains a large amount of endogenous 
porphyrin (30). 
Only a few studies describe the effect of PDT 
with Photofrin on normal tissues of the oral 
mucosa. Treatment protocols used in these 
studies differ from the present study, so conse- 
quently it is difficult to find analogies in PDT- 
induced (normal) tissue damage. Biel et al (24) 
studied the effect of PDT (630 nm) with Photo- 
frin (2 mg kg-1) and various (incident) light 
doses (20, 50, 80, 100 and 125 J cm 2) in normal 
tissues of the oral cavity and larynx in dogs. 
Similar to the results of this study, the effects 
appeared to be tissue and light-dose depen- 
dent. The tongue was found to be more suscep- 
tible to PDT than cheek or larynx. The degree 
of oedema was found to be proportional to the 
degree of vascularization of the organ. Light 
doses of up to 50 J cm-2 gave reversible dam- 
age, which resulted in complete healing of the 
tongue by 7 weeks. A light dose greater than 
80 J cm -2 resulted in permanent ulceration 
with muscular fibrosis. The cheek mucosa was 
more resistant and tolerated treatments of up 
to 125 J cm-2 with minimal permanent tissue 
damage. These results are in accordance with 
the present results, where a combination of 
photosensitizer dose and light dose _>5 mg 
kg -1 and _>100 J cm -2 resulted in distinct 
permanent damage. Due to the smaller dimen- 
sion of the rat oral cavity, damage to several 
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anatomical structures beyond the mucosal 
layer were observed in the present study. 
Monnier et al (25) studied PDT 72 h after 
injection of Photofrin (2-3mg kg -1 bw) in 
normal buccal mucosa in humans. Light doses 
varied from 60-240 J cm-2 (5~200 mW cm-  2) 
and thermal effects were ruled out. A control 
group irradiated with a light dose of 240 J 
cm -2 but received no Photofrin, showed no 
necrosis of the buccal mucosa. Four days after 
PDT, all Photofrin-treated patients showed 
necrosis of the irradiated, normal buccal 
mucosa. Superficial necrosis was induced with 
- -2  light doses as low as 60 J cm 
In a clinical PDT study, Biel (31,32) 
described the treatment of 65 patients with 
neoplastic disease of the head and neck. 
Among these were seven patients with a T1 
squamous cell carcinoma of the tongue or the 
floor of the mouth. Patients were treated 48 h 
after injection of Photofrin (2.0 mg kg-  1) with 
630rim light at 50 75J cm 2 and 150mW 
cm 2. For tumours greater than 3 mm depth, 
cylindrical diffuser implants were used. No 
adverse reactions were described. The results 
of this study are very promising because PDT 
was found to be effective, especially in the 
treatment of T1 tumours and carcinoma in situ 
(CIS). However, much less impressive results 
were achieved in treating deeply4nvasive car- 
cinomas. The present authors fully agree with 
the conclusions of the study that adequate 
delivery of the laser light to the tumour bed 
plays an important role, and that it is difficult 
to compare or evaluate the effectiveness of 
PDT because of the lack of well-defined stan- 
dards for PDT treatments with regard to drug 
dosage, light delivery systems and optical 
dosimetry. 
CONCLUSIONS 
Internal reflection and light scattering have a 
strong influence on the true-light fluence in 
tissue. Normal tissues do retain the photo- 
sensitizer and are susceptible to PDT. The 
amount of PDT-induced amage was found to 
be photosensitizer and light-dose dependent. 
An additional aim of this study was to define 
a treatment window for PDT of chemically 
induced dysplastic lesions and squamous cell 
carcinoma of the rat palatal mucosa. In this 
study, combinations of photosensitizer >_5 mg 
kg-1 and light _>100J cm-2 resulted in 
distinct permanent damage. As damage to 
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normal  t issues shou ld  be at least  revers ib le ,  
these  va lues  def ine the  upper  l imits  of  the  
t reatment  window.  Fur thermore ,  the use of  
l ight  of  514.5 nm seems to be more  appropr ia te  
for PDT of  super f ic ia l  mucosa l  les ions than  
625 nm because  it is capab le  of  adequate ly  
exc i t ing  porphyr in  w i thout  damaging  struc-  
tures  at  deeper  levels.  In  humans ,  the dimen- 
s ions in the ora l  cav i ty  are  much la rger  than  in 
rats,  so the effects of  depth  of  penet ra t ion  to 
sur round ing  anatomica l  s t ruc tures ,  wi l l  be far  
less devasta t ing  than  those  descr ibed in th is  
study. Never the less ,  th is  s tudy shows that  ana- 
tomica l  s t ruc tures  beyond the  ta rget  vo lume 
are prone  to permanent  PDT damage.  Phenom-  
ena, such  as the occur rence  of  ep i the l ia l  inc lu-  
s ion cysts, anky los i s  of  teeth ,  pulp necros i s  
and necros i s  of  bone,  ser ious ly  compl i ca te  
c l in ica l  app l i ca t ion  of  PDT in the  ora l  reg ion.  
Add i t iona l  in  v ivo  PDT stud ies  are, there fore ,  
needed to fu r ther  es tab l i sh  opt ima l  t reatment  
pro toco ls  and to def ine the  t rue  mer i t  of  
PDT in the  t reatment  of  p remal ignant  and 
mal ignant  les ions of  the  ora l  mucosa.  
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